Literature DB >> 2709679

The delayed effect of growth hormone on renal function in humans.

R Hirschberg1, H Rabb, R Bergamo, J D Kopple.   

Abstract

Growth hormone is reported to increase renal plasma flow (RPF) and glomerular filtration rate (GFR) in some but not all studies. The discrepant results could be due to a delay in the effects of growth hormone on renal function. We therefore examined whether a growth hormone injection does increase RPF and GFR, whether this increase is delayed, and whether elevation in RPF and GFR is associated with increased plasma levels of insulin-like growth factor I (IGF-I). Seven normal adults received a single intramuscular injection of growth hormone, 0.15 mg/kg, and serial PAH and inulin clearances were then monitored for three consecutive days. Plasma growth hormone levels peaked an average of 2.25 hours after injection, at 128 +/- 12 SEM ng/ml, and then began to decrease; on the second day values were only slightly elevated and on the third day they were not different from baseline. Plasma IGF-I, analyzed by direct radioimmunoassay, did not change on the first day during 5.5 hours of measurements after injection. By the second day, plasma IGF-I was elevated to over twice baseline levels (P less than 0.05) and remained elevated on the third day (P less than 0.05). RPF and GFR did not change from baseline (546 +/- 19 and 100 +/- 3 ml/min/1.73 m2, respectively) during the 5.5 hours after injection on the first day.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2709679     DOI: 10.1038/ki.1989.65

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport.

Authors:  R Quigley; M Baum
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

2.  Randomised controlled trial of recombinant human growth hormone in prepubertal and pubertal renal transplant recipients. British Association for Pediatric Nephrology.

Authors:  H Maxwell; L Rees
Journal:  Arch Dis Child       Date:  1998-12       Impact factor: 3.791

3.  Treatment of short stature in renal disease with recombinant human growth hormone.

Authors:  L Rees; S P Rigden; G Ward; M A Preece
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

4.  Effect of growth hormone on urine calcium and serum vitamin D metabolites in renal failure.

Authors:  C F Strife; G Hug
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

5.  Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat.

Authors:  R Hirschberg; J D Kopple; R C Blantz; B J Tucker
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

Review 6.  An approach to protein restriction in children with renal insufficiency.

Authors:  N G Raymond; J T Dwyer; P Nevins; P Kurtin
Journal:  Pediatr Nephrol       Date:  1990-03       Impact factor: 3.714

Review 7.  Renal cellular biology of growth hormone and insulin-like growth factor I.

Authors:  M R Hammerman; S B Miller
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

8.  Effects of growth hormone administration in pediatric renal allograft recipients.

Authors:  S Bartosh; B Kaiser; I Rezvani; M Polinsky; S Schulman; J Palmer; H J Baluarte
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

9.  Differential effects of recombinant human growth hormone on glomerular filtration rate and renal plasma flow in chronic renal failure.

Authors:  H Maxwell; D R Nair; R N Dalton; S P Rigden; L Rees
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

Review 10.  Influence of growth hormone and insulin-like growth factor-I on kidney function and kidney growth.

Authors:  E Ritz; B Tönshoff; S Worgall; G Kovacs; O Mehls
Journal:  Pediatr Nephrol       Date:  1991-07       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.